How 200 Snake Bites Became an Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax

How 200 Snake Bites Became an Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax

June 16, 2026 · 34 min · Episode 26025

About this episode

Dr. Jake Glanville discusses the development of a groundbreaking antivenom vaccine inspired by a survivor of multiple snake bites.

This week on BioTech Nation, a call to a man who survived hundreds of venomous snake bites helps inspire the development of an antivenom vaccine. Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of this Biotech Breakthrough – from the first telephone call through each significant step, all leading to the first breakthrough generalized antivenom vaccine in 125 years.

More episodes of BioTech Nation ... with Dr. Moira Gunn

Explore listener stats, chart rankings, contacts and more on the BioTech Nation ... with Dr. Moira Gunn podcast page.